Estimation of potency of HERG channel blockers: Impact of voltage protocol and temperature
Authors:
- Jian-An YaoJYJian-An Yao
- Xiaoyi DuXDXiaoyi Du
- Daniel LuDLDaniel Lu
- Robert L. BakerRBRobert L. Baker
- Eric DaharshEDEric Daharsh
- Philip AttersonPAPhilip Atterson
- 1 July 2005
- journal article
- research article
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 52 (1) , 146-153
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Variability in the measurement of hERG potassium channel inhibition: Effects of temperature and stimulus patternJournal of Pharmacological and Toxicological Methods, 2004
- Preferential closed channel blockade of HERG potassium currents by chemically synthesised BeKm‐1 scorpion toxinFEBS Letters, 2003
- Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug developmentCardiovascular Research, 2003
- A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugsEuropean Journal of Pharmacology, 2002
- 14‐3‐3 amplifies and prolongs adrenergic stimulation of HERG K+ channel activityThe EMBO Journal, 2002
- Cardiotoxicity of new antihistamines and cisaprideToxicology Letters, 2002
- Regulation of the cardiac repolarizing HERG potassium channel by protein kinase A.Trends in Cardiovascular Medicine, 2000
- QT interval prolongation by non-cardiovascular drugs: issues and solutions for novel drug developmentPharmaceutical Science & Technology Today, 1999
- Modulation of human erg K+ channel gating by activation of a G protein‐coupled receptor and protein kinase CThe Journal of Physiology, 1998
- A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERGFEBS Letters, 1997